Detalhe da pesquisa
1.
Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancer.
Cell
; 185(16): 2848-2849, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931017
2.
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks.
Immunity
; 57(2): 287-302.e12, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354704
3.
Stem-cell-like CD4+ T cells prey on MHC class II-negative tumors.
Nat Immunol
; 24(8): 1212-1214, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460640
4.
HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Blood
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683966
5.
De novo design of potent and selective mimics of IL-2 and IL-15.
Nature
; 565(7738): 186-191, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30626941
6.
NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness.
Blood
; 140(21): 2261-2275, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605191
7.
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Lancet Oncol
; 24(7): 811-822, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414012
8.
Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1.
Nat Immunol
; 12(10): 984-91, 2011 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21892175
9.
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Blood
; 137(3): 323-335, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967009
10.
Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8(+) central memory T cells.
Immunity
; 41(1): 116-26, 2014 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25035956
11.
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.
Blood
; 135(19): 1650-1660, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076701
12.
High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy.
Blood
; 134(7): 636-640, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648294
13.
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.
Blood
; 134(19): 1585-1597, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558469
14.
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.
Blood
; 133(15): 1652-1663, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728140
15.
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Blood
; 133(17): 1876-1887, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782611
16.
Cytomegalovirus Exposure in the Elderly Does Not Reduce CD8 T Cell Repertoire Diversity.
J Immunol
; 202(2): 476-483, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30541882
17.
Chimeric antigen receptor-modified T cells: CD19 and the road beyond.
Blood
; 131(24): 2621-2629, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29728402
18.
Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy.
Blood
; 131(1): 121-130, 2018 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29038338
19.
Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy.
J Immunol
; 200(2): 459-468, 2018 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29311388
20.
Role of memory T cell subsets for adoptive immunotherapy.
Semin Immunol
; 28(1): 28-34, 2016 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976826